Ketamine Therapy Cost: Infusion, Spravato & KAP Pricing (2026)
What ketamine therapy actually costs in 2026, broken out by format — IV infusions, esketamine (Spravato), and ketamine-assisted psychotherapy — plus which types insurance actually covers.
Ketamine therapy costs $400 to $1,200 per IV infusion, $700 to $1,200 per Spravato (esketamine) dose, or $400 to $1,200 per ketamine-assisted psychotherapy (KAP) session — and which format you choose changes both the total price and whether insurance will pay any of it. A standard six-session IV course runs $2,400 to $7,200 out of pocket; a Spravato induction month runs $4,000 to $9,500 self-pay but often drops to a $10-$60 copay with insurance.
Those three formats get confused constantly because they all involve the same drug. This guide breaks out pricing for each one separately, since the cost — and the insurance picture — is genuinely different for each.
75%
Three Formats, Three Price Tags
"Ketamine therapy" covers three distinct ways of receiving the drug, and providers rarely explain upfront how differently each one is priced:
| Format | What It Is | Self-Pay Per Session |
|---|---|---|
| IV ketamine infusion | Ketamine delivered through a vein over ~40 minutes at a clinic | $400 – $1,200 |
| Esketamine (Spravato) | FDA-approved nasal spray, self-administered under 2-hour clinic observation | $700 – $1,200 |
| Ketamine-assisted psychotherapy (KAP) | Lower-dose ketamine (often IM or sublingual) combined with a talk-therapy session in the same visit | $400 – $1,200 |
The sections below cover what drives the price within each format and what insurance will and won't touch.
IV Ketamine Infusion Cost
IV infusions are the most clinically studied format and the one most "ketamine clinics" default to.
Per-Session and Full-Course Pricing
IV Ketamine Infusion Cost by Setting
| Setting | Cost Per Infusion | 6-Infusion Course |
|---|---|---|
| Standalone ketamine clinic | $400 - $800 | $2,400 - $4,800 |
| Anesthesiologist-led practice | $500 - $950 | $3,000 - $5,700 |
| Integrative psychiatry / hospital-affiliated program | $600 - $1,200 | $3,600 - $7,200 |
A typical initial course is six infusions over two to three weeks. After that, most people need maintenance infusions — commonly every four to eight weeks — at $400 to $1,200 each, so ongoing annual cost (including the initial course) often lands between $5,000 and $12,000.
Ask for a complete fee schedule before starting. Many clinics bill the intake evaluation ($150-$300) and any integration therapy ($100-$250 per session) separately from the infusion fee itself.
Does Insurance Cover IV Ketamine?
Almost never for psychiatric use. IV ketamine is prescribed off-label for depression, anxiety, and PTSD, and most commercial insurers, Medicare, and Medicaid do not reimburse it for those indications. Some clinics will issue a superbill you can submit for possible out-of-network reimbursement, but approval is inconsistent and not something to count on when budgeting.
Spravato (Esketamine) Cost
Esketamine — the brand name is Spravato — is chemically related to ketamine but is FDA-approved, which changes the cost picture substantially.
What It Costs Without Insurance
The drug itself has a wholesale list price of roughly $590 for a 56 mg dose and $885 for an 84 mg dose; most patients start at the lower dose and step up if tolerated. Add the clinic's required two-hour post-dose observation fee (typically $150-$400), and a single self-pay session runs $700 to $1,200.
The standard induction schedule is twice weekly for four weeks (8 doses), so a full induction month without insurance costs $4,000 to $9,500.
What It Costs With Insurance
This is where Spravato differs sharply from IV ketamine: because it's FDA-approved for treatment-resistant depression and for depression with acute suicidal ideation, most commercial plans, Medicare Part D, and many state Medicaid programs cover it with prior authorization.
$10-$60
To get coverage, your prescriber typically has to document that you've tried and failed at least two standard antidepressants from different classes. The manufacturer's patient assistance program (Janssen CarePath) can bring eligible patients' copays down to as little as $10 per session even during the appeal or authorization process.
Ketamine-Assisted Psychotherapy (KAP) Cost
KAP is the format most often left out of cost guides, but it's increasingly common — and priced differently from either of the above.
What Makes KAP Different
Instead of just administering the drug and monitoring vitals, KAP bundles a lower, sub-dissociative or moderate dose of ketamine (usually intramuscular or sublingual, sometimes IV) with an actual psychotherapy session — preparation, the dosing experience itself, and in-session or follow-up integration work with the same therapist. The therapy is the point, not an add-on.
KAP Pricing
Ketamine-Assisted Psychotherapy Cost
| Component | Typical Cost |
|---|---|
| Single KAP session (dosing + therapy combined) | $400 - $1,200 |
| Prep-only or integration-only follow-up session | $150 - $350 |
| Full initial course (6-8 sessions over 2-3 months) | $3,000 - $6,400 |
KAP sessions run longer than a standard infusion visit — often 2 to 3 hours — because the therapist stays with you through the dosing and immediate aftermath rather than just a nurse monitoring vitals. That's the main reason per-session pricing sits close to IV infusion pricing even though the ketamine dose itself is often lower.
Does Insurance Cover KAP?
Rarely, and only partially. The ketamine portion is billed the same off-label way as IV infusions, so insurance typically won't touch it. Some KAP providers split billing: the psychotherapy portion may be billable to insurance under standard mental health CPT codes if the therapist is in-network, while the ketamine/medical portion stays self-pay. Ask any KAP provider upfront which parts of the visit they bill separately — this is the single biggest source of surprise bills in this format.
Comparing All Three Formats
Ketamine Therapy Cost by Format
| Format | Per-Session Self-Pay | Typical Initial Course | Insurance Coverage |
|---|---|---|---|
| IV infusion | $400 - $1,200 | $2,400 - $7,200 (6 sessions) | Rare — off-label use |
| Spravato (esketamine) | $700 - $1,200 | $4,000 - $9,500 (8 doses) | Often covered with prior auth |
| Ketamine-assisted psychotherapy (KAP) | $400 - $1,200 | $3,000 - $6,400 (6-8 sessions) | Partial — therapy hour only, sometimes |
If insurance coverage matters most to your budget, Spravato is the format with the clearest path to getting a large share of the cost covered. If you specifically want the drug combined with structured talk therapy in the same visit, KAP is the format built for that — you'll just want to confirm billing details first.
Ways to Lower the Cost
- Ask about Spravato before IV ketamine if cost is the deciding factor. The insurance pathway exists for Spravato in a way it generally doesn't for IV ketamine or KAP.
- Use the Janssen CarePath program. It's specific to Spravato and can reduce copays to as little as $10 per session for eligible patients, even while prior authorization is pending.
- Ask about sliding-scale or payment plans. Many independent ketamine and KAP clinics offer income-based discounts or multi-month payment plans for the self-pay portion.
- Use an HSA or FSA. Ketamine treatment for a diagnosed mental health condition typically qualifies as an eligible medical expense. See our guide to paying for therapy with an HSA or FSA for how to confirm eligibility with your plan administrator.
- Check if your plan covers the therapy portion of KAP separately. If your KAP provider's therapist is in-network, the psychotherapy hour may be billable even when the ketamine itself isn't — worth a call to your insurer before assuming the whole visit is self-pay.
Frequently Asked Questions
It depends on the format. IV infusions typically cost $400 to $1,200 per session self-pay. Spravato (esketamine) runs $700 to $1,200 per dose including the required monitoring fee. Ketamine-assisted psychotherapy (KAP) sessions, which bundle dosing with a therapy hour, typically cost $400 to $1,200 per visit.
It depends heavily on the format. IV ketamine infusions are almost never covered because they're used off-label for depression, anxiety, and PTSD. Spravato (esketamine) is FDA-approved for treatment-resistant depression and is often covered by commercial insurance, Medicare Part D, and many Medicaid plans with prior authorization. Ketamine-assisted psychotherapy sometimes gets partial coverage for the talk-therapy portion only, if the therapist is in-network.
IV ketamine infusions are typically cheaper per session ($400-$1,200) but almost never covered by insurance, since they're prescribed off-label. Spravato costs somewhat more per dose ($700-$1,200 self-pay) but is FDA-approved, which means most commercial insurers and Medicare will cover it with prior authorization — often bringing the actual out-of-pocket cost down to a $10-$60 copay per session.
A standard six-session IV infusion course runs $2,400 to $7,200 depending on the clinic. A Spravato induction month (8 doses) runs $4,000 to $9,500. A ketamine-assisted psychotherapy course of 6 to 8 sessions over two to three months typically runs $3,000 to $6,400. All three usually require ongoing maintenance sessions after the initial course.
Ketamine-assisted psychotherapy (KAP) combines a moderate ketamine dose with an in-session psychotherapy component, administered by or alongside a trained therapist rather than just a monitoring nurse. Sessions run longer (often 2-3 hours) and include preparation and integration work, which is why per-session pricing is closer to IV infusion pricing even though the ketamine dose is often lower.
Generally yes, for any of the three formats, when the treatment is for a diagnosed mental health condition. Ketamine infusions, Spravato, and KAP typically qualify as eligible medical expenses under a Health Savings Account or Flexible Spending Account. Confirm with your plan administrator and ask your provider for documentation showing medical necessity.
Spravato (esketamine) went through FDA clinical trials specifically for psychiatric use and carries an official indication for treatment-resistant depression and depression with suicidal ideation. IV ketamine, by contrast, is an older generic anesthetic being prescribed off-label for psychiatric conditions — it was never submitted through that same FDA approval pathway for mental health use, so insurers treat it as an unproven, non-covered use of an approved drug.
Weighing Ketamine Against Other Treatment-Resistant Options?
Ketamine is one of several options once standard antidepressants and therapy haven't worked. See how it compares to TMS, ECT, and combined approaches.
Read the Treatment-Resistant Depression Guide